Synopsis of recent research by authors named "Wenhe Zhu"
- Wenhe Zhu's recent research primarily focuses on enhancing the therapeutic efficacy of dihydroartemisinin (DHA) through innovative nanotechnology approaches, addressing challenges related to its poor solubility and bioavailability for cancer treatment and anti-parasitic applications.
- Zhu's studies include the development of various drug delivery systems, such as redox-responsive prodrugs and self-assembled nanoparticles, aimed at improving the selective targeting and release mechanisms of DHA, ultimately facilitating its clinical use in cancers and infections.
- Additionally, Zhu's work contributes to the creation of responsive biomaterials for antibacterial applications, highlighting the urgent need for effective treatments against urinary tract infections and pathogen-related diseases, thereby bridging the gap between material science and biomedical applications.